M&A / Deals AstraZeneca, GSK intensify China ties with Sino Biopharm deals BioPharma DiveThe U.K.Read full story pharminent July 8, 2026 (Last updated: July 9, 2026) BioPharma Dive The U.K. Read full story Post navigation Previous: AstraZeneca bets up to $1.9B in respiratory disease collab with Sino BiopharmaceuticalNext: Tanabe pens deal to sell plants to Towa in post-buyout pivot Related Stories M&A / Deals BioMarin spends up to $490m for Alesta’s bone disease candidate pharminent August 19, 2026 M&A / Deals J&J hands lymphoma bispecific CAR T back to AbelZeta pharminent August 17, 2026 M&A / Deals Novo Nordisk and AWS form AI partnership to speed drug discovery pharminent August 17, 2026
